Anavex Life Sciences Ownership | Who Owns Anavex Life Sciences?


OverviewForecastFinancialsChartTranscripts

Anavex Life Sciences Ownership Summary


Anavex Life Sciences is owned by 34.72% institutional investors, 3.06% insiders, and 62.22% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 7.85% of AVXL shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.98% of its assets in Anavex Life Sciences shares.

AVXL Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAnavex Life Sciences34.72%3.06%62.22%
SectorHealthcare Stocks 57.47%9.40%33.13%
IndustryBiotech Stocks 69.06%8.93%22.01%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de6.55M7.85%$70.37M
Blackrock6.39M7.75%$26.97M
Vanguard group4.68M5.61%$50.27M
State street2.41M2.84%$25.90M
Geode capital management1.87M2.25%$20.14M
Susquehanna group, llp1.13M1.36%$12.19M
Nwam913.05K1.09%$9.81M
Two sigma investments, lp776.90K0.93%$8.34M
Northern trust669.16K0.81%$2.82M
Charles schwab investment management677.22K0.81%$7.27M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Pier capital441.92K0.68%$4.75M
Nwam913.05K0.61%$9.81M
Allsquare wealth management51.97K0.32%$558.12K
Saxon interests25.69K0.12%$275.88K
Prairiewood capital20.80K0.10%$223.39K
Heartland advisors155.85K0.09%$1.67M
Hikari power85.58K0.08%$919.00K
Watts gwilliam26.00K0.07%$349.96K
Scientech research19.14K0.06%$205.61K
Sculptor capital lp370.10K0.05%$3.97M

Top Buyers

HolderShares% AssetsChange
Susquehanna group, llp1.13M0.00%896.32K
Invesco615.05K0.00%590.64K
Pier capital441.92K0.68%441.92K
Essential planning, llc.413.09K0.02%413.09K
Ubs group418.76K0.00%288.71K

Top Sellers

HolderShares% AssetsChange
Wealthgarden f.s.---910.48K
Jupiter asset management---804.64K
State street2.41M0.00%-654.02K
Bank of america corp /de/175.90K0.00%-388.80K
Blackrock6.39M0.00%-254.07K

New Positions

HolderShares% AssetsChangeValue
Pier capital441.92K0.68%441.92K$4.75M
Essential planning, llc.413.09K0.02%413.09K$3.25M
Wellington management group llp158.67K0.00%158.67K$1.70M
Heartland advisors155.85K0.09%155.85K$1.67M
Jump financial153.23K0.03%153.23K$1.65M

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-14.00
Russell investments group-115.00
Capital performance advisors llp-135.00
Bangor savings bank-150.00
Colonial trust advisors-200.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202418017.65%29,442,0845.60%343.11%9838.03%3822.58%
Sep 30, 20241511.34%27,864,8824.09%323.13%7216.13%30-33.33%
Jun 30, 2024148-6.33%26,770,748-15.94%322.16%62-17.33%44-
Mar 31, 2024158-5.39%31,845,74223.59%383.94%75-11.76%4415.79%
Dec 31, 20231679.87%25,766,5323.24%313.30%8519.72%38-15.56%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv2.53M2.98%-
iShares Russell 2000 ETF1.96M2.31%-38.50K
Vanguard Institutional Extnd Mkt Idx Tr1.27M1.49%383.00
SPDR® S&P Biotech ETF797.12K0.94%6.04K
Fidelity Small Cap Index764.15K0.90%-1.08K
iShares Russell 2000 Value ETF523.93K0.62%-1.07K
iShares Biotechnology ETF505.38K0.59%-4.38K
Fidelity Extended Market Index468.98K0.55%1.56K
State St Russell Sm/Mid Cp® Indx NL Cl C433.20K0.51%-
Schwab US Small-Cap ETF™406.24K0.48%-

Recent Insider Transactions


DateNameRoleActivityValue
Jun 14, 2024Donhauser Peter D.O.-Buy$10.32K
May 15, 2024Thomas Steffen-Buy$22.60K
Mar 28, 2024MISSLING CHRISTOPHER U President and CEOSell$374.97K
Jun 28, 2023MISSLING CHRISTOPHER U President and CEOSell$2.14M
May 25, 2022Skarpelos Athanasios Sell$453.00K

Insider Transactions Trends


DateBuySell
2024 Q21-
2024 Q1-1
2023 Q2-1
2023 Q1--
2022 Q2-1

AVXL Ownership FAQ


Who Owns Anavex Life Sciences?

Anavex Life Sciences shareholders are primarily institutional investors at 34.72%, followed by 3.06% insiders and 62.22% retail investors. The average institutional ownership in Anavex Life Sciences's industry, Biotech Stocks , is 69.06%, which Anavex Life Sciences falls below.

Who owns the most shares of Anavex Life Sciences?

Anavex Life Sciences’s largest shareholders are Blackrock funding, inc. /de (6.55M shares, 7.85%), Blackrock (6.39M shares, 7.75%), and Vanguard group (4.68M shares, 5.61%). Together, they hold 21.21% of Anavex Life Sciences’s total shares outstanding.

Does Blackrock own Anavex Life Sciences?

Yes, BlackRock owns 7.75% of Anavex Life Sciences, totaling 6.39M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 26.97M$. In the last quarter, BlackRock decreased its holdings by -254K shares, a -3.82% change.

Who is Anavex Life Sciences’s biggest shareholder by percentage of total assets invested?

Pier capital is Anavex Life Sciences’s biggest shareholder by percentage of total assets invested, with 0.68% of its assets in 441.92K Anavex Life Sciences shares, valued at 4.75M$.

Who is the top mutual fund holder of Anavex Life Sciences shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Anavex Life Sciences shares, with 2.98% of its total shares outstanding invested in 2.53M Anavex Life Sciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools